Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 6.52 Delayed Data As of Mar 24 |  +0.31 / +4.99%Today’s Change | 1.77 Today|||52-Week Range 9.22 | +137.09% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | -- | -- |
| Depreciation And Amortization | -- | -- | 20.3K | -- | ||
| Operating Expenses | Gross Income | 0.00 | 0.00 | -20.3K | -- | |
| General Expenses | 1.9M | 4.5M | 21.9M | -- | ||
| Research And Development | 1.7M | 3.7M | 12.8M | -- | ||
| Total Operating Expenses | 1.9M | 4.5M | 21.9M | -- | ||
| Non-Operating Expenses | Operating Income | -1.9M | -4.5M | -21.9M | -- | |
| Interest Expense On Debt | 0.00 | 2.0K | 0.00 | -- | ||
| Other Expenses | 0.00 | 0.00 | -1.0K | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -1.9M | -4.5M | -20.6M | -- | |
| Preferred Dividend | 0.00 | -5.3M | 0.00 | -- | ||
| Net Income | -1.9M | -4.5M | -20.6M | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 25.7M | 25.7M | 14.7M | -- | |
| Shares To Calculate EPS Diluted | 25.7M | 25.7M | 14.7M | -- | ||
| Earnings Per Share | EPS | -$0.07 | -$0.57 | -$1.41 | -- | |
| EPS Diluted | -$0.07 | -$0.38 | -$1.41 | -- | ||
